Table 1. Expenditure on consumables under three methods of health-care financing before and after implementation of the results-based financing programme in Zambia, April 2012 to June 2014.
Group | Population in millions | Expenditure, US$ |
Expenditure per quarter per capita, US$ |
||||
---|---|---|---|---|---|---|---|
Before programme (5 quarters) | After programme (9 quarters) | Before programme | After programme | Difference | |||
Results-based financing | 1.33 | 1 694 470 | 6 991 502 | 0.26 | 0.59 | 0.33 | |
Input-based financing | 1.26 | 3 097 135 | 8 489 457 | 0.50 | 0.77 | 0.27 | |
Control | 1.40 | 2 924 591 | 8 062 629 | 0.42 | 0.64 | 0.22 |
US$: United States dollars.
Notes: Results-based financing facilities received increased funding tied to performance on pre-agreed indicators; input-based financing facilities received increased funding not tied to performance; control facilities were under the usual funding system without additional financing in Zambia. There were 175, 173 and 175 primary health-care facilities in the results-based financing, input-based financing and control groups, respectively. Costs of consumables (e.g. drugs and supplies) were obtained from a data set compiled by Medical Stores Limited, the national pharmaceutical distribution hub, from January 2011 through June 2014.